Replies to post #28015 on Radient Pharmaceuticals Corporation fka RXPC

[livinginsv]

i bet it's the 2011 lenders en banc

and by april mac defaulted, my turning point . . .

[guardiangel]

It appears Provista Diagnostics foreign registration certificate for Videssa is experiencing a SNAFU at the moment. One thing is for certain..When they roll out, it will be international and domestic...Who has those international distributors and contacts?
RADIENT/AMDL you understand..imo wolf

VIDESSA
Status653 - Suspension Letter - Mailed
Status Date2015-02-14




2015-01-28 TEAS RESPONSE TO OFFICE ACTION RECEIVED
2015-01-28 CORRESPONDENCE RECEIVED IN LAW OFFICE
2015-01-29 TEAS/EMAIL CORRESPONDENCE ENTERED
2015-02-14 SUSPENSION LETTER WRITTEN
2015-02-14 LETTER OF SUSPENSION E-MAILED
2015-02-14 NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

https://trademarks.justia.com/863/83/videssa-86383350.html

mb Videssa didn't like her/his name being used...lol

Videssa Djucich

Marketing Director at Virgo Publishing

Phoenix, Arizona Area
Publishing

https://www.linkedin.com/pub/videssa-djucich/13/99b/73b




*****************************************************************


Word MarkPROTEOMARK
Status686 - Published For Opposition
Status Date2015-03-03
Filing Date2014-11-18

https://trademarks.justia.com/864/57/proteomark-86457327.html

[guardiangel]

AMDL Diagnostics Inc.


The name is not available for reservation.


http://www.corp.delaware.gov/onlinestatus.shtml

The name 'RADIENT PHARMACEUTICALS CORPORATION' is available.
The cost for this reservation is $ 75.00.

[guardiangel]

William stated in an interview before Jul 25, 2010,where they filed 65 patents in foreign countries in 2010 alone..

http://www.bizjournals.com/phoenix/stories/2010/07/26/focus3.html

Less than 3 months later...The announcement came out on the collaboration of LC Sentinel. The Provista Diagnostics Test with the use of DR-70.Those 65 patents belong to Provista Diagnostics and Radient by the confidentiality agreement by law and common sense....Some would say Provista Diagnostics Provista Diagnostics is not pursuing the lung cancer test, but our great DD has proved them wrong from our recent Russian find where PDX is pursuing investors in Russia and abroad with that Lung cancer Test...65 patents filed is a huge investment to just ignore you understand...imo Wolf

TUSTIN, CA--(Marketwire - 10/13/10) - Provista Life Sciences and Radient Pharmaceuticals Corporation (RPC) (AMEX:RPC - News) announced today the validation study results of a blood test for early detection of lung cancer and Provista's plans to broadly introduce this new test to market.The study completed the requisite analyses and data evaluation needed to validate Provista's test, based on Radient Pharmaceutical Corporation's antigens for fibrinogen degradation products (FDP), successfully detects lung cancer with a high degree of accuracy. The study included men and women between 20-76 years of age. The data generated in this final study proved consistent with previous findings and produced positive clinical performance marks of 87% sensitivity; 95% specificity; and an ROC Accuracy of 0.97.
http://finance.yahoo.com/news/Radient-Pharmaceuticals-and-iw-1271623575.html
*****************************************************************
Sound off: Patents

William Gartner

William Gartner

1. How many patent applications has your company filed overall, and how many were this year?

2. What has the application process been like for you, and what do you think of the time frame for a response?

3. What do you think of the latest U.S. Supreme Court ruling affecting the patent process, and how will it affect your competitive edge?
William Gartner
President and CEO, Provista Life Sciences LLC

APPLICATIONS: Counting foreign countries, we have filed 186 patents on five different technologies. That includes all of our foreign patents, and approximately 65 of those have been filed this year in the individual countries.

PROCESS: The application process is simple to us because we do so many and have a great bioscience patent attorney.

RULING: The new ruling will have no impact on us. The ACLU v. the U.S. Patent Office and Myriad Genetics will have a huge positive impact on our business if the Supreme Court rules that genes cannot be patented.